全球智慧型胰島素筆市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，智慧胰島素筆市場規模將達到 25.237 億美元，高於 2025 年的 9.3306 億美元，預計從 2026 年到 2034 年的複合年成長率將達到 11.69%。

隨著數位醫療技術革新糖尿病管理方式，全球智慧胰島素筆市場正快速成長。智慧胰島素筆是一種先進的設備，可幫助患者注射胰島素，同時追蹤劑量、注射時間和使用模式。這些設備通常與行動應用程式配合使用，使用戶和醫療專業人員能夠更有效地監測胰島素的輸注。全球糖尿病盛行率的不斷上升，顯著推動了對這些創新設備的需求。

市場成長的促進因素包括對改善糖尿病管理的需求日益成長以及患者對胰島素治療的依從性提高。智慧胰島素筆提供劑量提醒、自動追蹤和與醫療專業人員共用數據等功能。這些功能有助於患者更好地控制血糖值，並降低劑量錯誤的風險。

智慧胰島素筆市場預計將受益於數位醫療技術的持續進步。與持續血糖監測系統和行動醫療平台的整合，可提供更全面的糖尿病管理解決方案。新興市場健康意識的提高和糖尿病護理服務覆蓋範圍的擴大，將進一步推動智慧胰島素筆的普及。隨著數位醫療解決方案的不斷發展，智慧胰島素筆仍將是糖尿病治療的重要工具。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球智慧胰島素筆市場：連結性

• 市場分析、洞察與預測
• Bluetooth
• 近距離場通訊（NFC）

第5章：全球智慧胰島素筆市場：依適應症分類

• 市場分析、洞察與預測
• 1型糖尿病
• 2型糖尿病

第6章：全球智慧胰島素筆市場：依通路分類

• 市場分析、洞察與預測
• 醫院藥房
• 實體店和網路藥局

第7章 全球智慧胰島素筆市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Novo Nordisk A/S
  • Medtronic
  • Ypsomed AG
  • Emperra GmbH
  • Pendiq
  • Jiangsu Deflu Medical Device Co
  • Cambridge Consultants Ltd
  • Diabnext

The Smart Insulin Pens Market size is expected to reach USD 2523.70 Million in 2034 from USD 933.06 Million (2025) growing at a CAGR of 11.69% during 2026-2034.

The global smart insulin pens market has grown rapidly as digital health technologies transform diabetes management. Smart insulin pens are advanced devices that help patients administer insulin while tracking dosage, timing, and usage patterns. These devices often connect to mobile applications, allowing users and healthcare providers to monitor insulin administration more effectively. The increasing global prevalence of diabetes has significantly contributed to the demand for these innovative devices.

Several factors are driving market growth, including the rising need for improved diabetes management and patient adherence to insulin therapy. Smart insulin pens offer features such as dose reminders, automatic tracking, and data sharing with healthcare professionals. These capabilities help patients maintain better control over blood glucose levels and reduce the risk of dosing errors.

Looking forward, the smart insulin pens market is expected to benefit from continued advancements in digital healthcare technologies. Integration with continuous glucose monitoring systems and mobile health platforms may provide more comprehensive diabetes management solutions. Increasing healthcare awareness and expanding access to diabetes care in emerging markets will likely drive further adoption. As digital health solutions continue to evolve, smart insulin pens will remain an important tool in diabetes treatment.

MARKET SEGMENTATION

By Connectivity

• Bluetooth
• Near Field Communication (NFC)

By Indication

• Type 1 Diabetes
• Type 2 Diabetes

By Distribution Channel

• Hospital Pharmacies
• Retail & Online Pharmacies

COMPANIES PROFILED

• Novo Nordisk AS, Medtronic, Ypsomed AG, Emperra GmbH, Pendiq, Jiangsu Deflu Medical Device Co, Cambridge Consultants Ltd, Diabnext
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SMART INSULIN PENS MARKET: BY CONNECTIVITY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Connectivity
• 4.2. Bluetooth Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Near Field Communication (NFC) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SMART INSULIN PENS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Type 1 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Type 2 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SMART INSULIN PENS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail & Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SMART INSULIN PENS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Connectivity
  • 7.2.2 By Indication
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Connectivity
  • 7.3.2 By Indication
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Connectivity
  • 7.4.2 By Indication
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Connectivity
  • 7.5.2 By Indication
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Connectivity
  • 7.6.2 By Indication
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SMART INSULIN PENS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Novo Nordisk A/S
  • 9.2.2 Medtronic
  • 9.2.3 Ypsomed AG
  • 9.2.4 Emperra GmbH
  • 9.2.5 Pendiq
  • 9.2.6 Jiangsu Deflu Medical Device Co
  • 9.2.7 Cambridge Consultants Ltd
  • 9.2.8 Diabnext